Fig. 3From: Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathologyQuantification of CK2α/α’ immunoreactivity in the temporal cortex of CON and AD patients. Quantification of CK2α/α’ positivity in the temporal cortex (grey matter) of AD patients (n = 8) and non-demented controls (CON, n = 8). Mean levels (± SD) of the area density are expressed as percentage of immunoreactive area of the total area. *p value <.05Back to article page